Clinical Trials Browser

RC48 antibody × Genitourinary × 90 days × Clear all

NCT07608224 2026-05-27

HOPE-07-MIBC

Phase 2/3 Not yet recruiting

Urinary Bladder Neoplasms

NCT05911295 2026-04-20

Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2

Phase 3 Active not recruiting

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell